In this thesis, the potential success of a novel drug delivery system (PDAL DDS) in the current antifungal DDS market was evaluated. Focus was placed …
Background: Following the Food and Drug Administration’s (FDA) controversial approval of aducanumab, a monoclonal antibody for the treatment of Alzheimer’s disease, CMS used its National …